The Short And Long-Term Outlook For Moderna’s Stock

Moderna Inc (NASDAQ: MRNA) is a phenomenal long-term investment, but the stock could be volatile ahead of the FDA Advisory Committee meetings this week, Short Hills Capital’s Steve Weiss said Wednesday on CNBC.

The FDA is set to hold Thursday its Vaccines and Related Biological Products Advisory Committee meeting to discuss the use of booster doses of the Moderna COVID-19 vaccine.

“It’s sort of like good news bad news because their vaccine is so effective the efficacy is only dropping from 95%…

Read More